Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | TYR | P14679 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | FYN | P06241 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | GAA | P10253 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | HPN | P05981 | 1/20 | 0.34 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | GMNN | O75496 | 1/20 | 0.34 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18468337 | 1.00 | CA2 (0.38) | CA2CA1ALDH1A1POLBTYR | |
| SCHEMBL19224339 | 0.92 | CA2 (0.36) | CA2CA1ALDH1A1POLBTYR | |
| SCHEMBL9936660 | 0.90 | CA2 (0.35) | CA2CA1ALDH1A1POLBTYR | |
| SCHEMBL25693911 | 0.89 | ALDH1A1 (0.36) | CA2CA1ALDH1A1POLBTYR | |
| SCHEMBL25693909 | 0.89 | ALDH1A1 (0.36) | CA2CA1ALDH1A1POLBTYR | |
| SCHEMBL25693907 | 0.89 | ALDH1A1 (0.36) | CA2CA1ALDH1A1POLBTYR | |
| SCHEMBL19224336 | 0.88 | CA2 (0.40) | CA2CA1ALDH1A1POLBTYR | |
| SCHEMBL9937454 | 0.88 | ALDH1A1 (0.34) | CA2CA1ALDH1A1POLBTYR | |
| SCHEMBL13554274 | 0.87 | NR5A2 (0.32) | FYN | |
| SCHEMBL19619072 | 0.87 | CYP2C9 (0.35) | ALDH1A1KDM4EMAPTLMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 256 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4259748-B1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2025-07-30 | — | — | EP | disclosed |
| US-12043781-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2024-07-23 | — | — | US | disclosed |
| EP-4400561-A1 | LIQUID-CRYSTAL MEDIUM | Merck Patent GmbH (DE) | 2024-07-17 | — | — | EP | disclosed |
| US-20240228878-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME | DIC CORPORATION (JP) | 2024-07-11 | — | — | US | disclosed |
| US-20240228878-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME | DIC CORPORATION (JP) | 2024-07-11 | — | — | US | disclosed |
| US-12024665-B2 | Polymer-stabilized liquid crystal composition and use thereof | BEIJING BAYI SPACE LCD TECHNOLOGY CO., LTD. (CN) | 2024-07-02 | — | — | US | disclosed |
| US-12024665-B2 | Polymer-stabilized liquid crystal composition and use thereof | BEIJING BAYI SPACE LCD TECHNOLOGY CO., LTD. (CN) | 2024-07-02 | — | — | US | disclosed |
| WO-2024133363-A1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2024-06-27 | — | — | WO | disclosed |
| WO-2024133361-A1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2024-06-27 | — | — | WO | disclosed |
| US-20240067879-A1 | Liquid-crystal medium | MERCK PATENT GMBH (DE) | 2024-02-29 | — | — | US | disclosed |
| US-20140111730-A1 | Liquid-crystalline medium, method for the stabilization thereof, and liquid-crystal display | MERCK PATENT GMBH (DE) | 2014-04-24 | — | — | US | disclosed |
| US-20140111730-A1 | Liquid-crystalline medium, method for the stabilization thereof, and liquid-crystal display | MERCK PATENT GMBH (DE) | 2014-04-24 | — | — | US | disclosed |
| EP-2722381-A2 | Liquid crystal medium, method for the stabilisation thereof and liquid crystal display | Merck Patent GmbH (DE) | 2014-04-23 | — | — | EP | disclosed |
| EP-2652088-A1 | LIQUID-CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2013-10-23 | — | — | EP | disclosed |
| US-20130258268-A1 | LIQUID-CRYSTALLINE MEDIUM AND ELECTRO-OPTICAL DISPLAY | MERCK PATENT GMBH (DE) | 2013-10-03 | — | — | US | disclosed |
| US-20130258268-A1 | LIQUID-CRYSTALLINE MEDIUM AND ELECTRO-OPTICAL DISPLAY | MERCK PATENT GMBH (DE) | 2013-10-03 | — | — | US | disclosed |
| US-20120268706-A1 | COMPOUNDS AND LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-10-25 | — | — | US | disclosed |
| EP-2514800-A2 | Compounds and liquid crystalline medium | Merck Patent GmbH (DE) | 2012-10-24 | — | — | EP | disclosed |
| WO-2012079710-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2012-06-21 | — | — | WO | disclosed |
| WO-2012076104-A1 | LIQUID CRYSTAL MEDIUM AND ELECTROOPTIC DISPLAY | MERCK PATENT GMBH (DE) | 2012-06-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120268706-A1 | COMPOUNDS AND LIQUID-CRYSTALLINE MEDIUM | NEFM, VIM, FLNB | CA2 1948/4885CA1 998/4885ALDH1A1 3557/4885 |
| US-20240228878-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME | TTI2, CCT4, CCT2 | CA2 615/4885CA1 273/4885ALDH1A1 4223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.